A simple p53 functional assay for screening cell lines, blood, and tumors
- PMID: 7732013
- PMCID: PMC42082
- DOI: 10.1073/pnas.92.9.3963
A simple p53 functional assay for screening cell lines, blood, and tumors
Abstract
Mutations in the p53 gene are implicated in the pathogenesis of half of all human tumors. We have developed a simple functional assay for p53 mutation in which human p53 expressed in Saccharomyces cerevisiae activates transcription of the ADE2 gene. Consequently, yeast colonies containing wild-type p53 are white and colonies containing mutant p53 are red. Since this assay tests the critical biological function of p53, it can distinguish inactivating mutations from functionally silent mutations. By combining this approach with gap repair techniques in which unpurified p53 reverse transcription-PCR products are cloned by homologous recombination in vivo it is possible to screen large numbers of samples and multiple clones per sample for biologically important mutations. This means that mutations can be detected in tumor specimens contaminated with large amounts of normal tissue. In addition, the assay detects temperature-sensitive mutants, which give pink colonies. We show here that this form of p53 functional assay can be used rapidly to detect germline mutations in blood samples, somatic mutations in tumors, and mutations in cell lines.
Similar articles
-
Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.Mol Carcinog. 1997 Mar;18(3):171-6. Mol Carcinog. 1997. PMID: 9115587
-
Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.J Urol. 1999 Jun;161(6):1973-5. J Urol. 1999. PMID: 10332483
-
Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.Oncol Rep. 2005 Oct;14(4):901-7. Oncol Rep. 2005. PMID: 16142349
-
FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.Neoplasma. 1999;46(2):80-8. Neoplasma. 1999. PMID: 10466430 Review.
-
[Functional screening of p53 status in tumor cells using Saccharomyces cerevisiae].Gan To Kagaku Ryoho. 1997 Feb;24(4):466-70. Gan To Kagaku Ryoho. 1997. PMID: 9063485 Review. Japanese.
Cited by
-
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.PLoS One. 2012;7(12):e48993. doi: 10.1371/journal.pone.0048993. Epub 2012 Dec 13. PLoS One. 2012. PMID: 23272046 Free PMC article.
-
p53: a molecular marker for the detection of cancer.Expert Opin Med Diagn. 2008 Sep;2(9):1013-24. doi: 10.1517/17530059.2.9.1013. Expert Opin Med Diagn. 2008. PMID: 23495923 Free PMC article.
-
Whole-genome cartography of p53 response elements ranked on transactivation potential.BMC Genomics. 2015 Jun 17;16(1):464. doi: 10.1186/s12864-015-1643-9. BMC Genomics. 2015. PMID: 26081755 Free PMC article.
-
Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70.PLoS Genet. 2010 Jan;6(1):e1000807. doi: 10.1371/journal.pgen.1000807. Epub 2010 Jan 8. PLoS Genet. 2010. PMID: 20066033 Free PMC article.
-
Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.J Mol Diagn. 2000 Aug;2(3):139-44. doi: 10.1016/S1525-1578(10)60629-0. J Mol Diagn. 2000. PMID: 11229518 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous